Johnson & Johnson (JNJ)

Healthcare · Pharmaceuticals · Price $265.85
Updated: Sep 1, 2026
Elevated Multiple — Healthcare
P/E of 30.87x is above the 28x moderate threshold — significant growth expectations already priced in.
P/E Ratio (TTM)
30.87x
High P/E - significant growth expectations
Earnings Yield
3.24%
1 / P/E Ratio
EPS (TTM)
$8.61
Diluted Earnings Per Share
Stock Price
$265.85
Current Market Price
PEG Ratio
-999.00
Negative growth - PEG not meaningful
Earnings Growth
-1.12%
Net Income Growth (Linear)

🧮 JNJ P/E Ratio Calculation

P/E Ratio = Stock Price ÷ Earnings Per Share (TTM)
Stock Price $265.85
÷
Earnings Per Share (TTM) $8.61
= P/E Ratio 30.87x

What is the P/E Ratio?

The Price-to-Earnings (P/E) Ratio is one of the most widely used valuation metrics. It tells you how much investors are willing to pay for each dollar of a company's earnings. Zyberno calculates P/E using trailing twelve month (TTM) diluted earnings from official SEC filings.

P/E Ratio = Stock Price ÷ Earnings Per Share (TTM)
Using diluted EPS which accounts for stock options and convertible securities

How to Interpret the P/E Ratio

Low P/E (Under 15x)

May indicate undervaluation, or the market expects declining earnings. Common in mature, slow-growth industries.

Average P/E (15-20x)

Roughly in line with historical S&P 500 average. Suggests fairly valued with moderate growth expectations.

High P/E (20-35x)

Investors expect above-average earnings growth. Common for technology companies and market leaders.

Very High P/E (35x+)

Extreme growth expectations priced in. Significant valuation risk if growth slows.

PEG Ratio: P/E Adjusted for Growth

The PEG Ratio addresses a key limitation of P/E by factoring in earnings growth. A PEG of 1.0 suggests fair value; below 1.0 may indicate undervaluation, while above 2.0 suggests a premium price for growth.

PEG Ratio = P/E Ratio ÷ Earnings Growth Rate
JNJ: 30.87x ÷ -1.12% = -999.00

P/E Ratio Limitations

The P/E ratio doesn't work for companies with negative earnings. It can be manipulated by one-time charges or gains, and it doesn't account for debt levels or growth rates. Use P/E alongside PEG ratio, EV/EBITDA, and Owner Earnings yield for a complete picture.

Comparing Valuation Metrics

EPS: $8.61 →

The denominator in the P/E calculation. Represents profit allocated to each outstanding share.

Price-to-Book: N/A

Compares stock price to book value. Useful for asset-heavy industries like banking and manufacturing.

EV/EBITDA: N/A

Accounts for debt and is useful for comparing companies with different capital structures.

Owner Earnings Yield →

Warren Buffett's preferred metric. Shows cash return to owners as a percentage of market cap.

📊 Full JNJ Stock Report

Intrinsic value, margin of safety, DCF valuation, and 250+ metrics.

📈 JNJ Earnings Per Share

Deep dive into EPS trends, quarterly history, and earnings growth analysis.

🏆 JNJ ROIC

Measure capital efficiency — how well management deploys every dollar invested.

💎 JNJ Intrinsic Value

Calculate what JNJ is truly worth using DCF and Owner Earnings models.

💵 JNJ Owner Earnings

Warren Buffett's preferred measure of true earning power and cash generation.

🛡️ JNJ Margin of Safety

See if JNJ is trading below its intrinsic value.

View Full JNJ Report Find More Quality Stocks
📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$73.65
🛡️
Margin of Safety
Valuation Gap
-100.0%
🎯
Expected Return
Projected Annual
-25.7%
Click any metric for full methodology and detailed analysis

Summary: JNJ P/E Ratio

Johnson & Johnson (JNJ) trades at a P/E of 30.87x, which Zyberno classifies as an elevated multiple for a Healthcare company — above the 28x moderate threshold for healthcare companies where pipeline value and patent protection justify premium multiples, with significant growth expectations already priced in. Earnings yield: 3.24%.

Based on 0 quarters of SEC filings, JNJ's EPS is currently $8.61 on a trailing twelve-month basis. Zyberno cross-references the P/E ratio with business quality — a high multiple on a high-quality business (strong ROE, ROIC, and FCF) carries less risk than the same multiple on a weaker business. For complete financial analysis, view the full JNJ stock report on Zyberno.

Frequently Asked Questions

What is JNJ's current P/E Ratio?

Johnson & Johnson's trailing twelve month (TTM) P/E Ratio is 30.87x, within the context of Healthcare sector multiples where Zyberno considers 18–28x moderate. Investors are paying $30.87 for every $1 of annual earnings.

Is JNJ's P/E Ratio high or low?

Johnson & Johnson (JNJ) trades at a P/E of 30.87x, which Zyberno classifies as an elevated multiple for a Healthcare company — above the 28x moderate threshold for healthcare companies where pipeline value and patent protection justify premium multiples, with significant growth expectations already priced in. Earnings yield: 3.24%.

What is JNJ's earnings yield?

JNJ's earnings yield is 3.24%, which is the inverse of the P/E ratio (1 ÷ P/E). This represents the theoretical return if all earnings were distributed to shareholders.

How is P/E Ratio calculated?

P/E Ratio = Stock Price ÷ EPS. For JNJ: $265.85 ÷ $8.61 = 30.87x.

What is JNJ's PEG Ratio?

JNJ's PEG Ratio is -999.00. Negative growth - PEG not meaningful. PEG below 1.0 is often considered undervalued, while above 2.0 may indicate overvaluation relative to growth.

📊 Full JNJ Stock Report

See JNJ's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

🏆 JNJ ROIC

Compare to Return on Invested Capital — the most comprehensive measure of capital efficiency.

📈 JNJ ROE

Compare to Return on Equity and understand the impact of leverage on returns.

🎯 JNJ Earnings Surprise (SUE)

See whether JNJ is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

👤 JNJ Owner Earnings

Warren Buffett's preferred measure of true economic earnings available to owners.

💰 JNJ Net Income

See the bottom-line profit that drives return calculations.

📊 JNJ EPS

Earnings per share — net income on a per-share basis.

View Full JNJ Report Find More Quality Stocks
Scroll to Top